To enable long-lasting symptom control of adult spasticity, Dysport^® should be injected at the recommended dose in the approved muscles. For every Dysport^® injection, dosing should be tailored to the individual based on the size, number and location of muscles, severity of spasticity, any local muscle weakness, and the patient’s response to previous treatment and adverse event history.¹

The dosing recommendations in the Dysport^® SmPC should always be followed:¹

Adult spasticity dilution tables²

Retreating: treatment may be repeated every 12–16 weeks based on clinical symptom return (or longer, as necessary, but not before 12 weeks).^*1

Locating injection sites: although actual location of injection sites can be determined by palpation, use of injection guiding techniques, e.g. electromyography, electrical stimulation or ultrasound, is recommended to target injections.¹

The recommended doses per treatment session for each upper limb and lower limb muscle group can be viewed in the administration guides below.

*The degree and pattern of muscle spasticity at the time of re-injection may necessitate alterations in the dose of Dysport^® and muscles to be injected.¹

References:

1. Dysport^® Summary of Product Characteristics.
2. Dysport^® dosing and administration guide.

Abbreviations:

SmPC, Summary of Product Characteristics; U, units.

For further information, please refer to the Prescribing Information or the Summary of Product Characteristics.